needles social support haemostasis management haemostasis management what is haemostasis disease areas introduction educational links growth hormone therapy growth hormone therapy is my child growing normally what is growth hormone growth hormone pens patient organisations hormone replacement therapy hormone replacement therapy health care professionals health care professionals diabetes diabetes is a chronic condition caused by the body s inability to produce or make use of insulin haemostasis management haemophilia is an inherited congenital bleeding disorder that affects males . growth hormone therapy growth hormone is crucial to the healthy development and functioning of the human body hormone replacement therapy hrt is used to treat climacteric symptoms of women in different stages of the menopause novo nordisk pro novo nordisk pro is the official novo nordisk online resource exclusively for healthcare professionals careers careers join us available jobs email job agent unsolicited applications working at novo nordisk moving to denmark life changing careers magazine meet us event calendar career paths research & development manufacturing corporate functions marketing & sales career programmes phd and postdocs medical doctors quality management programme graduates students and trainees graduates students trainees internships pages in danish ledige stillinger hvorfor novo nordisk ans ttelsesprocessen uopfordret ans gning elev i novo nordisk about novo nordisk about novo nordisk novo nordisk in brief novo nordisk in brief facts and figures ownership our positions our logo stories novo nordisk way novo nordisk way novo nordisk way essentials our history our history the founders changing diabetes changing diabetes changing diabetes initiatives world diabetes day type 2 diabetes test changing haemophilia changing haemophilia changing haemophilia focus areas world haemophilia day management board of directors and executive management corporate governance how we are managed directed and controlled download ir materials download reports magazines and presentations contact us media r & d sustainability investors partnering novo nordisk worldwide half of the people with diabetes don t know they have it what is the biggest risk in your city leading up to world diabetes day on november 14 we took to the streets to find out how much people know about type 2 diabetes . see the film and take the test to know your risk we need to getthis right six mayors city and health leaders offer their views on what is central to un s new urban agenda . read the open letter diabetes on the curriculum when it comes to diabetes care going back to school can be just what the doctor ordered . learn more in our latest issue of tbl quarterly patients ideas matter a new award will celebrate innovations in diabetes care made by the people who have the deepest knowledge of living with the disease . read more about the lyfebulb innovation award follow us on twitter stay updated on how we drive change to defeat diabetes and other serious chronic conditions . novo nordisk live live tweeting from major events around the world . products and services content is for health care professionals only . please choose a therapy area . diabetes care haemostasis management growth hormone therapy hormone replacement therapy news novo nordisk receives complete response letter in the us for faster acting insul ... 07 oct 2016 novo nordisk announces plans to reduce workforce by approximately 1 000 employee ... 29 sep 2016 read more news we offer 0 job opportunities denmark 14 us 28 china 18 brazil 3 cambodia 1 canada 2 france 3 germany 6 india 42 israel 2 malaysia 1 myanmar 4 nepal 1 philippines 1 russia 7 ukraine 3 united kingdom 1 vietnam 3 denmark 13 us 32 china 10 brazil 2 cambodia 1 canada 4 france 1 germany 2 india 41 israel 4 malaysia 1 myanmar 4 nepal 1 philippines 1 russia 7 thailand 1 ukraine 3 united kingdom 1 vietnam 3 search overview accessibility who we are novo nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care . this heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions haemophilia growth disorders and obesity . headquartered in denmark novo nordisk employs approximately 42 300 people in 75 countries and markets its products in more than 180 countries . novo nordisk websites novo nordisk in the usa novo nordisk in denmark or choose country sites usa algeria argentina australia austria belgium brazil bulgaria canada chile china colombia croatia czech republic denmark estonia finland france germany greece hong kong hungary india ireland israel italy japan latvia lithuania mexico moldova netherlands new zealand norway pakistan poland portugal russia serbia slovakia slovenia south korea spain sweden switzerland taiwan tunisia turkey ukraine united kingdom usa venezuela other sites dawn study clinical trials hero study novo nordisk haemophilia foundation cities changing diabetes novo nordisk foundation novo a s novo nordisk worldwide addresses and global contacts shareholder information share info annual reporting annual report 2015 contact quick links customer service and feedback report a side effect report product complaints report falsified products report a concern to the compliance hotline media contact comments to our website please provide required fields . your country please choose country albaniaalgeriaangolaargentinaarmeniaaustraliaaustriaazerbaijanbahrainbangladeshbelarusbelgiumbeninbosnia and herzegovinabotswanabrazilbulgariaburkina fasoburundicambodiacamerooncanadacape verdecentral african republicchadchilechinacolombiacomoroscongo democratic republiccroatiacyprusczech republicdenmarkdjiboutiegyptequatorial guineaeritreaestoniaethiopiafinlandfrancegabongambiageorgiagermanyghanagreeceguineaguinea bissauhong konghungaryicelandindiaindonesiairaniraqirelandisraelitalyivory coastjapanjordankazakhstankenyakosovokuwaitkyrgyzstanlaoslatvialebanonlesotholiberialibyalithuanialuxembourgmacedoniamadagascarmalawimalaysiamaldivesmalimaltamauritaniamauritiusmexicomoldovamongoliamontenegromoroccomozambiquemyanmarnamibianetherlandsnew zealandnigernigerianorwayomanpakistanperuphilippinespolandportugalqatarromaniarussian federationrwandasao tome and principesaudi arabiasenegalserbiaseychellessierra leonesingaporeslovak republicsouth koreasloveniasomaliasouth africasouth sudanspainsri lankast.helenasudanswazilandswedenswitzerlandsyriataiwantajikistantanzaniathailandtogotunisiaturkeyturkmenistanugandaukraineunited arab emiratesunited kingdomusauzbekistanvenezuelavietnamyemenzambiaother country topic please choose topic diabetes caregrowth hormone therapyhaemophilia managementhormone replacement therapyinvestor relationsother attachment your email message thank you for contacting us your e mail has been sent successfully . we will get back to you as soon as possible . 2016 novo nordisk a s disclaimer privacy sitemap